FasL - Too much of a good thing

被引：36

作者：

Lau, HT ^{[1
]}

Stoeckert, CJ ^{[1
]}

机构：

[1] CHILDRENS HOSP PHILADELPHIA,DIV HEMATOL,PHILADELPHIA,PA 19104

来源：

NATURE MEDICINE | 1997年 / 3卷 / 07期

关键词：

D O I：

10.1038/nm0797-727

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

Transplanted grafts of pancreatic islet cells engineered to express Fas ligand are destroyed not protected by the immune system (pages 738–743).

引用

页码：727 / 728

页数：2

共 9 条

[1] Transgenic expression of CD95 ligand on islet beta cells induces a granulocytic infiltration but does not confer immune privilege upon islet allografts [J].

Allison, J ;

Georgiou, HM ;

Strasser, A ;

Vaux, DL .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1997, 94 (08) :3943-3947

[2] A ROLE FOR CD95 LIGAND IN PREVENTING GRAFT-REJECTION [J].

BELLGRAU, D ;

GOLD, D ;

SELAWRY, H ;

MOORE, J ;

FRANZUSOFF, A ;

DUKE, RC .

NATURE, 1995, 377 (6550) :630-632

[3] The role of Fas in autoimmune diabetes [J].

Chervonsky, AV ;

Wang, Y ;

Wong, FS ;

Visintin, I ;

Flavell, RA ;

Janeway, CA ;

Matis, LA .

CELL, 1997, 89 (01) :17-24

[4] FAS LIGAND-INDUCED APOPTOSIS AS A MECHANISM OF IMMUNE PRIVILEGE [J].

GRIFFITH, TS ;

BRUNNER, T ;

FLETCHER, SM ;

GREEN, DR ;

FERGUSON, TA .

SCIENCE, 1995, 270 (5239) :1189-1192

[5] Fas ligand expression in islets of Langerhans does not confer immune privilege and instead targets them for rapid destruction [J].

Kang, SM ;

Schneider, DB ;

Lin, ZH ;

Hanahan, D ;

Dichek, DA ;

Stock, PG ;

Baekkeskov, S .

NATURE MEDICINE, 1997, 3 (07) :738-743

[6] Cotransplantation of allogeneic islets with allogeneic testicular cell aggregates allows long-term graft survival without systemic immunosuppression [J].

Korbutt, GS ;

Elliott, JF ;

Rajotte, RV .

DIABETES, 1997, 46 (02) :317-322

[7] Prevention of islet allograft rejection with engineered myoblasts expressing FasL in mice [J].

Lau, HT ;

Yu, M ;

Fontana, A ;

Stoeckert, CJ .

SCIENCE, 1996, 273 (5271) :109-112

[8] FAS AND FAS LIGAND - LPR AND GLD MUTATIONS [J].

NAGATA, S ;

SUDA, T .

IMMUNOLOGY TODAY, 1995, 16 (01) :39-43

[9]

SWENSON K, 1997, 23 ANN M AM SOC THER

← 1 →